Director, President, CEO · ANAPTYSBIO, INC · Common Stock
Side
SELL
Value
$33K
Shares
550
Price
$60.63
Executed
Mar 27, 2026
Disclosed
Mar 27, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Mar 27 executedMar 27, 2026 disclosed
ANAB · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Faga Daniel filed this Form 4 reporting a open-market sale of ANAB on Mar 27, 2026. It became public on Mar 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President, CEO
Faga Danielcik:0001673528
Issuer
ANAPTYSBIO, INCcik:0001370053
Revision history · 0
No field has changed since this record was first ingested.
